/People

Evan Schnell

Investor

Venture Partner at Kaleida Capital

Find your path to Evan

Sign up to see every warm intro you have to Evan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Evan. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Evan Schnell is a Venture Partner at Kaleida Capital with over 25 years building and commercializing clinical-grade software across brain-computer interfaces, neuromodulation, and healthcare infrastructure. He is currently Director of Medical Device Software at Axoft and was previously Senior Director of Software at Synchron, and earlier a Principal Software Engineer at Medtronic contributing to the Percept DBS system, with prior roles at McKesson and RelayHealth. He holds an MBA from the University of Minnesota Carlson School of Management and advises Kaleida on NeuroAI, BCI, and regulated digital health.

Invests in

AI & Machine LearningDigital HealthHealthtechMedical Devices

Colleagues at Kaleida Capital

Frequently asked questions

Who is Evan Schnell?
Evan Schnell is a Venture Partner at Kaleida Capital with over 25 years building and commercializing clinical-grade software across brain-computer interfaces, neuromodulation, and healthcare infrastructure. He is currently Director of Medical Device Software at Axoft and was previously Senior Director of Software at Synchron, and earlier a Principal Software Engineer at Medtronic contributing to the Percept DBS system, with prior roles at McKesson and RelayHealth. He holds an MBA from the University of Minnesota Carlson School of Management and advises Kaleida on NeuroAI, BCI, and regulated digital health.
Where does Evan Schnell work?
Evan Schnell is Venture Partner at Kaleida Capital.
What does Evan Schnell invest in?
Evan Schnell invests in AI & Machine Learning, Digital Health, Healthtech, Medical Devices.

About this profile. Compiled from public sources — Kaleida Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights